N-(4-Methoxybenzyl)efavirenz is a pharmaceutical impurity reference standard used in quality control and analytical testing. It is a derivative of efavirenz, modified with a 4-methoxybenzyl group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 174819-21-7
Tonabersat
pharmaceutical raw material
Levomilnacipran hydrochloride
pharmaceutical raw material
Gemifloxacin
pharmaceutical raw material
Lacosamide
pharmaceutical raw material
(4S)-6-chloro-4-(2-cyclopropylethynyl)-1-[(4-methoxyphenyl)methyl]-4-(trifluoromethyl)-3,1-benzoxazin-2-one
BKYROQXKHLSLOS-NRFANRHFSA-N
COC1=CC=C(C=C1)CN2C3=C(C=C(C=C3)Cl)[C@@](OC2=O)(C#CC4CC4)C(F)(F)F